Summary of Previous Postings

Summary for 2014

Date:Monday Jul 21, 2014

Title:Combined MEK, BRAF inhibitors promising in melanoma

Abstract:Combined treatment of BRAFV600-mutated melanoma with the MEK inhibitor cobimetinib and the BRAF inhibitor vemurafenib was safe and tolerable, according to the results of a phase Ib study. Summary. Background Addition of a MEK inhibitor to a BRAF inhibitor enhances tumour growth inhibition, delays acquired resistance, and abrogates paradoxical activation of the MAPK pathway in preclinical models of BRAF-mutated melanoma.

Genetic defect may increase melanoma susceptibility (19.Jul.14)
New prognostic factors may help in staging melanoma (16.Jul.14)
New approach identifies mutations as targets of effective melanoma immunotherapy (11.Jul.14)
New online wiki-based site offers evidence-based skin cancer information (08.Jul.14)
Surgical treatment for metastatic melanoma of the liver increases overall survival (02.Jul.14)
Young indoor tanners at higher risk for early basal cell carcinoma (01.Jul.14)
Routine sun exposure may trigger an addictive pathway (26.Jun.14)
Researchers discover how ‘wriggling’ skin cancer cells go on the move (25.Jun.14)
New clues to skin cancer development show sunscreen is not enough (23.Jun.14)

View more Postings for 2014.

Summary for 2013

Predictors of sentinel lymph node metastasis in thin melanomas (18.Dec.13)
UVR hazard to New Zealand outdoor workers (17.Dec.13)
In-vitro fertilisation and melanoma (13.Dec.13)
Stage III/IV melanoma patients at risk for new primaries (12.Dec.13)
Pigmentation beyond scar’s edge in recurrent melanoma (10.Dec.13)
Intracranial, extracranial metastases in BRAF-mutant melanoma respond similarly to dabrafenib (09.Dec.13)
Communicating the location of potential skin neoplasms for excision (06.Dec.13)
High TIL grade of primary melanoma associated with lower death risk (05.Dec.13)
Research findings have potential to enhance melanoma treatment (02.Dec.13)
Global Controversies and Advances in Skin Cancer Conference (26.Nov.13)

View more Postings for 2013.

Summary for 2012

Potential drug combinations for difficult-to-treat melanomas (20.Dec.12)
More effective immunotherapy for melanoma hinges on blocking suppressive factors (18.Dec.12)
More Australian states ban sunbeds (17.Dec.12)
Victorian Skin Cancer Prevention Framework 2013-2017 (16.Dec.12)
Cancer Forum focus on skin cancer (11.Dec.12)

View more Postings for 2012.

Summary for 2011

Gene controlling melanoma spread identified (21.Dec.11)
Cancer information systems update (20.Dec.11)
NZ price of cancer report (20.Dec.11)
Indoor tanning and risk of early-onset basal cell carcinoma (19.Dec.11)
Impact of physician screening on melanoma detection (15.Dec.11)

View more Postings for 2011.

Summary for 2010

Burden of Cancer Report (29.Dec.10)
Drug-resistant melanomas require combination therapy (23.Dec.10)
Consensus vitamin D position statement (22.Dec.10)
Reduced melanoma after regular sunscreen use: randomized trial follow-up (07.Dec.10)
7th Edition of AJCC Melanoma Staging System (06.Dec.10)

View more Postings for 2010.

Summary for 2009

Thanks to our Sponsors
Sun Smart Melanoma HPA

Copyright © Melanoma Network of New Zealand 2009  |   Privacy Disclaimer